Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Inhaled Nitric Oxide May Reduce Surgical Complications

By HospiMedica International staff writers
Posted on 10 Jul 2018
Administration of nitric oxide (NO) during and following heart surgery can decrease risk of developing acute and chronic kidney problems, claims a new study.

Researchers at Fourth Military Medical University (Xi’an, China), Brigham and Women’s Hospital (BWH; Boston, MA, USA), Massachusetts General Hospital (MGH; Boston, USA), and other institutions conducted a randomized, controlled trial involving 244 adults in Xi'an (China), who underwent multiple valve replacement surgery. More...
The patients were randomized to receive 80 PPM of NO or of nitrogen alone, administered via a gas exchanger during cardiopulmonary bypass, and by inhalation for 24 hours post-operatively.

The results revealed that patients who received of NO during and for 24 hours after surgery were less likely to develop acute kidney injury (AKI), with a decrease from 64% in placebo-treated patients to 50% in those who received NO. Risk of progressing to stage 3 chronic kidney disease (CKD) was also reduced at 90 days, from 33% in placebo-treated patients to 21% in those who received NO. After one year, 31% of patients in the nitrogen placebo group had serious kidney disease, compared to 18% in the NO group. There was also a decrease in the overall one-year mortality rate, from 6% in the placebo group to 3% in the NO group. The study was published on June 22, 2018, in Journal of Respiratory and Critical Care Medicine.

“We tested whether administration of nitric oxide, a gas normally produced by cells in the lining of blood vessels, might render hemoglobin ‘inert’, thereby decreasing the risk of both acute and chronic kidney injury,” said co-lead author Lorenzo Berra, MD, medical director of respiratory care at MGH. “We believe that the older patients with an increased number of cardiovascular risk factors, including obesity, hypertension, and diabetes, may derive even greater benefit from nitric oxide administration during and after heart surgery.”

NO has been identified as an important molecule with versatile roles in human physiology, including selective pulmonary vasodilation, bronchodilator, and pulmonary surfactant activities to improve ventilation-perfusion mismatch and hence oxygenation. Clinical effects of nitric oxide gas include cardio-pulmonary vasodilation, reduction of right heart load, reduction of ischemia, reduction of hypoxemia, inhibition of platelet aggregation, and anti-inflammatory, fungicidal, virocidal, and bactericidal effects, among others.

Related Links:
Fourth Military Medical University
Brigham and Women’s Hospital
Massachusetts General Hospital


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Monitor/Defibrillator
Zenix
Surgical System
Stealth AXiS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image: The findings suggest that hematopoietic cell transplantation may benefit patients with Shwachman-Diamond syndrome soon after high-risk features are detected, before advanced malignancy develops. (Image Credit: Shutterstock)

Early Stem Cell Transplantation May Improve Survival in Rare Inherited Bone Marrow Disorder

Shwachman-Diamond syndrome (SDS) is a rare inherited bone marrow disorder that can progress to severe hematologic disease. More than 90% of affected children survive beyond age 20, but fewer than 30% live... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.